Amiodarone and the risk of cancer

@article{Su2013AmiodaroneAT,
  title={Amiodarone and the risk of cancer},
  author={Vincent Yi-Fong Su and Yu-wen Hu and Kun-Ta Chou and Shuo-Ming Ou and Yu-chin Lee and Elizabeth Ya-Hsuan Lin and Tzeng-Ji Chen and Cheng-hwai Tzeng and Chia-Jen Liu},
  journal={Cancer},
  year={2013},
  volume={119}
}
In postmarketing surveillance, the US Food and Drug Administration has reported the development of lung masses, thyroid cancer, and skin cancer after amiodarone therapy. 
Reply to Amiodarone and the risk of cancer: A nationwide population‐based study
TLDR
Guan et al established that high iodine intake appears to be a significant risk factor for the occurrence of BRAF mutations in the thyroid gland and therefore may be a risk factors for the development of papillary thyroid cancer.
Challenges of thyroid cancer management in amiodarone-treated patients: a case report
TLDR
This case report mirrors the challenges of thyroid cancer management in an amiodarone-treated patient with recurrent or persistent disease after conventional therapy by surgery and radioactive iodine.
Risk of cancer in patients with heart failure who use digoxin: a 10-year follow-up study and cell-based verification
TLDR
A cohort study for digoxin treatment for HF patients with a cell-based strategy that addresses the translation issue is combined, which revealed the complexity of personalized medicine.
Amiodarone and the risk of cancer: A nationwide population‐based study
TLDR
I read with interest the population-based cohort secondary analysis of the Taiwan National Health Insurance Research database and would suggest that the investigators comment on the value of correcting for multiple testing.
Risk of Second Primary Malignancies in Lung Cancer Survivors – The Influence of Different Treatments
TLDR
This study indicates that lung cancer may be a risk factor for SPM, and that patients with epidermal growth factor receptor mutant lung adenocarcinoma (associated with non-smokers) tend to receive TKI treatment, they might have fewer smoking-related SPMs.
Amiodarone Therapy for Cardiac Arrhythmias: Is It Associated with the Development of Cancers?
TLDR
There is a need for more definitive studies to be conducted to provide clinicians with a clear answer to the ever increasing evidence that suggests amiodarone therapy, especially with long-term use, may increase the potential risk of cancer development.
Amyloidosis and the risk of cancer: a nationwide population-based study
TLDR
The results indicate that amyloidosis may be associated with an increased risk of kidney cancer and hematologic malignancies, and this is currently the largest study to evaluate cancer risk among patients with amyloidsosis.
...
1
2
3
4
...

References

SHOWING 1-10 OF 35 REFERENCES
Amiodarone-induced pulmonary mass.
Amiodarone pulmonary toxicity presenting as a solitary lung mass.
TLDR
It is demonstrated that amiodarone may induce a localized lung lesion rather than diffuse pulmonary disease.
Amiodarone and the thyroid gland. A review.
TLDR
It is suggested that past or present thyroid disorder, as well as presence of antithyroid antibodies are contraindications for amiodarone therapy.
Amiodarone and the thyroid gland. A review.
TLDR
It is suggested that past or present thyroid disorder, as well as presence of antithyroid antibodies are contraindications for amiodarone therapy.
Amiodarone-induced pulmonary toxicity mimicking metastatic lung disease.
TLDR
A 65 year old man developed atrial arrhythmias secondary to a congestive cardiomyopathy which were resistant to quinidine and disopyramide but 4 months after starting the drug he developed increasing dyspnoea and radiological changes highly suggestive of metastatic lung disease.
Amiodarone-induced thyrotoxicosis and thyroid cancer: clinical, immunohistochemical, and molecular genetic studies of a case and review of the literature.
TLDR
A case of papillary thyroid carcinoma associated with type 2 AIT is reported and iodine-induced thyrotoxicosis is reported to be a well-known complication of amiodarone treatment.
Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge
TLDR
A 64 year old man receiving long term amiodarone treatment presented with dyspnea, cough, and weight loss and findings on FDG-PET scan were consistent with a malignant tumour.
Cancer risk in individuals with benign thyroid disorders.
TLDR
The findings indicate that thyroid disorders may be related to cancer risk of several specific sites other than the thyroid in women discharged with myxedema and nontoxic goiter.
...
1
2
3
4
...